医学名词词典
文献检索
全文求助
焦点文献
我的词汇本
我要上传名词
个人中心
登录
|
注册
首页
>
按专业查询名词
> 查询PubMed相关文献
返回上一级
名词信息
中 文 名:
脂蛋白代谢紊乱
英 文 名:
lipoprotein metabolism disorder
中文又称:
中文曾称:
名词来源:
所属专业:
内分泌科
所属类别:
临床检查名词
加入我的词汇本
Pubmed相关的文献
lipoprotein metabolism disorder
相关文献:
Familial hypercholesterolemia.
Bouhairie VE, Goldberg AC.
Cardiol Clin. 2015 May;33(2):169-79. doi: 10.1016/j.ccl.2015.01.001.
PMID:25939291
The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease.
van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL.
Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1558-1572. doi: 10.1016/j.bbamem.2017.04.006. Epub 2017 Apr 11.
PMID:28411170
Obesity and Dyslipidemia.
Nussbaumerova B, Rosolova H.
Curr Atheroscler Rep. 2023 Dec;25(12):947-955. doi: 10.1007/s11883-023-01167-2. Epub 2023 Nov 18.
PMID:37979064
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook.
Raja V, Aguiar C, Alsayed N, Chibber YS, ElBadawi H, Ezhov M, Hermans MP, Pandey RC, Ray KK, Tokgözoglu L, Zambon A, Berrou JP, Farnier M.
Atherosclerosis. 2023 Oct;383:117312. doi: 10.1016/j.atherosclerosis.2023.117312. Epub 2023 Sep 30.
PMID:37826864
An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases.
Law SH, Chan ML, Marathe GK, Parveen F, Chen CH, Ke LY.
Int J Mol Sci. 2019 Mar 6;20(5):1149. doi: 10.3390/ijms20051149.
PMID:30845751
Obesity and Dyslipidemia: A Review of Current Evidence.
Vekic J, Stefanovic A, Zeljkovic A.
Curr Obes Rep. 2023 Sep;12(3):207-222. doi: 10.1007/s13679-023-00518-z. Epub 2023 Jul 6.
PMID:37410248
Triglyceride-rich lipoproteins and cardiovascular diseases.
Xu D, Xie L, Cheng C, Xue F, Sun C.
Front Endocrinol (Lausanne). 2024 May 31;15:1409653. doi: 10.3389/fendo.2024.1409653. eCollection 2024.
PMID:38883601
Lipoprotein metabolism in familial hypercholesterolemia.
Chemello K, García-Nafría J, Gallo A, Martín C, Lambert G, Blom D.
J Lipid Res. 2021;62:100062. doi: 10.1016/j.jlr.2021.100062. Epub 2021 Mar 3.
PMID:33675717
Hepatic Lipid Metabolism Disorder and Atherosclerosis.
Zhang S, Hong F, Ma C, Yang S.
Endocr Metab Immune Disord Drug Targets. 2022;22(6):590-600. doi: 10.2174/1871530322666211220110810.
PMID:34931971
Modification of lipoprotein metabolism and function driving atherogenesis in diabetes.
Luciani L, Pedrelli M, Parini P.
Atherosclerosis. 2024 Jul;394:117545. doi: 10.1016/j.atherosclerosis.2024.117545. Epub 2024 Apr 17.
PMID:38688749
© Copyright 2021 鸿泰茂源 版权所有
All Rights Reserved
京ICP备11040441号-3